{"organizations": [], "uuid": "7fee54157e60f9c6e42fd0fdbb80e251fa703680", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180521.html", "section_title": "Archive News &amp; Video for Monday, 21 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-sesen-bio-reports-positive-3-mth-d/brief-sesen-bio-reports-positive-3-mth-data-from-vista-trial-of-vicinium-in-high-grade-nmibc-idUSASC0A338", "country": "US", "domain_rank": 408, "title": "BRIEF-Sesen Bio Reports Positive 3-Mth Data From VISTA Trial of Vicinium in High-Grade NMIBC", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.055, "site_type": "news", "published": "2018-05-22T03:33:00.000+03:00", "replies_count": 0, "uuid": "7fee54157e60f9c6e42fd0fdbb80e251fa703680"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-sesen-bio-reports-positive-3-mth-d/brief-sesen-bio-reports-positive-3-mth-data-from-vista-trial-of-vicinium-in-high-grade-nmibc-idUSASC0A338", "ord_in_thread": 0, "title": "BRIEF-Sesen Bio Reports Positive 3-Mth Data From VISTA Trial of Vicinium in High-Grade NMIBC", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "sesen bio inc", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 21 (Reuters) - Sesen Bio Inc:\n* PHASE 3 REGISTRATION TRIAL FOR NON-MUSCLE INVASIVE BLADDER CANCER ACHIEVES 42% COMPLETE RESPONSE RATE AT THREE MONTHS IN CARCINOMA IN SITU PATIENTS\n* TO DATE, VICINIUM HAS BEEN WELL-TOLERATED IN VISTA TRIAL\n* Reports Positive, Three-Month Data From VISTA Trial of Vicinium In High-Grade NMIBC Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-22T03:33:00.000+03:00", "crawled": "2018-05-22T19:30:09.010+03:00", "highlightTitle": ""}